Ready to use biodegradable and biocompatible artificial skin substitute and a method of preparation thereof
The present invention relates to a three-dimensional cell culture system which can be used to culture a variety of different cells (Human mesenchymal stem cells, Human fibroblast, Keratinocytes, fibroblast differentiated form mesenchymal stem cells in vitro and keratinocytes differentiated form mesenchymal stem cells in vitro) in vitro for continued periods of time. In the present invention, mesenchymal stem cells (MSCs) derived from bone marrow or umbilical cord are inoculated and grown on a pre-established scaffold or matrix made up of chitosan and gelatin. The developed tissue constructs contain cells, growth factors, cytokines and other regulatory factors secreted by cells. The developed bioengineered tissue constructs provide the support, growth factors and essential cytokines for wound healing. Developed tissue construct useful in the treatment of burns wound, diabetic foot ulcer wound and type of chronic skin wounds. It is helpful in healing and regeneration of skin tissue.
1. A method of manufacturing a three-dimensional scaffold polyelectrolyte complex (PEC), comprising:
preparing a gelatin polymer solution by dissolving gelatin at a concentration of 1% to 4% w/v at a temperature between 35 to 75° C.;
stirring the gelatin polymer solution at 2500 to 3200 rpm at a temperature between 15 to 30° C. for between 20 to 30 minutes;
introducing glacial acetic acid at a concentration between 0.5% to 2.5% w/v and at temperature between 15 to 30° C. for 5 to 15 minutes; and
introducing chitosan at a concentration between 0.5% to 2.5% w/v at a temperature range of 15 to 30° C. for 80 to 130 minutes to form a composite polymer solution.
2. The method according to claim 1 , further comprising drying the composite polymer solution.
3. The method according to claim 2 , wherein the drying comprises air drying at a relative humidity of 5% to 44% and at a temperature between 5 to 18° C.
4. The method according to claim 3 , wherein the air drying occurs at a relative humidity of about 20% and at a temperature of about 12° C.
5. The method according to claim 1 , further comprising cutting the three-dimensional scaffold PEC.
6. The method according to claim 2 , further comprising seeding stem cells onto the three-dimensional scaffold PEC.
7. The method according to claim 6 , wherein the stem cells comprise mesenchymal stem cells.
8. The method according to claim 6 , wherein the glacial acetic acid is introduced at a rate of about 1 mg/1 ml.
9. The method according to claim 1 , wherein the chitosan is introduced at a rate of about 1 mg/1 ml.
10. A method of manufacturing a three-dimensional scaffold polyelectrolyte complex (PEC), comprising:
preparing a gelatin polymer solution by dissolving gelatin at a concentration of 1% to 4% w/v at a temperature between 35 to 75° C.;
stirring the gelatin polymer solution at 2500 to 3200 rpm at a temperature between 15 to 30° C. for between 20 to 30 minutes;
introducing glacial acetic acid at a concentration between 0.5% to 2.5% w/v at a temperature between 15 to 30° C. for 5 to 15 minutes;
introducing chitosan at a concentration between 0.5% to 2.5% w/v at a temperature range of 15 to 30° C. for 80 to 130 minutes to form a composite polymer solution;
drying the composite polymer solution; and
seeding mesenchymal stem cells onto the three-dimensional scaffold PEC at a cell density of 0.1×10 6 to 0.5×10 6 cell/cm 2 .
11. The method according to claim 10 , wherein the drying comprises air drying at a relative humidity of 5% to 44% and at a temperature between 5 to 18° C.
12. The method according to claim 11 , wherein the air drying occurs at a relative humidity of about 20% and at a temperature of about 12° C.
13. The method according to claim 10 , further comprising cutting the three-dimensional scaffold PEC.
14. The method according to claim 10 , wherein the glacial acetic acid is introduced at a rate of about 1 mg/1 ml.
15. The method according to claim 10 , wherein the chitosan is introduced at a rate of about 1 mg/1 ml.